Literature DB >> 23756333

Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events.

Sanne Willems1, Aryan Vink, Ilze Bot, Paul H A Quax, Gert Jan de Borst, Jean-Paul P M de Vries, Sander M van de Weg, Frans L Moll, Johan Kuiper, Petri T Kovanen, Dominique P V de Kleijn, Imo E Hoefer, Gerard Pasterkamp.   

Abstract

AIMS: Human autopsy, animal, and cell culture studies together have merged in a concept suggesting participation of mast cells (MCs) in the generation of atherosclerotic plaques. More specifically, these studies have suggested MC-induced intraplaque neovascularization as one mechanism by which MCs may render the plaques vulnerable. The present study was designed to assess the association between MC numbers and neovascularization in human atherosclerotic plaques, and to relate the abundance of plaque MCs to the occurrence of adverse cardiovascular events during the follow-up. METHODS AND
RESULTS: Atherosclerotic plaques of 270 patients suffering from carotid artery stenosis were stained for the presence of MCs (MC tryptase). Furthermore, during a follow-up of 3 years, cardiovascular-related endpoints were assessed in 253 patients. On average a high number of MCs were observed per plaque cross-section [median 108 (55-233) cells per section]. Plaques with high MC numbers revealed an unstable lipid-rich inflammatory phenotype and were associated with symptomatic patients. In addition, MC numbers were positively associated with microvessel density (r = 0.416, P < 0.001). Patients with high intraplaque MC numbers showed significantly more cardiovascular events during the follow-up (58/142 vs. 31/111 events, P = 0.029). In a multivariate analysis with correction for the main risk factors of cardiovascular diseases, MCs remained independently associated with adverse cardiovascular events (P = 0.025).
CONCLUSION: Mast cells are highly prevalent in human carotid atherosclerotic lesions and associated with plaque microvessel density. Furthermore, intraplaque MC numbers associate with future cardiovascular events.

Entities:  

Keywords:  Atherosclerosis; Inflammation; Intraplaque neovascularization; Mast cells; Unstable plaque

Mesh:

Substances:

Year:  2013        PMID: 23756333     DOI: 10.1093/eurheartj/eht186

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  20 in total

1.  Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study.

Authors:  Matthew J Feinstein; Petra Buzkova; Nels C Olson; Margaret F Doyle; Colleen M Sitlani; Alison E Fohner; Sally A Huber; James Floyd; Arjun Sinha; Edward B Thorp; Alan Landay; Matthew S Freiberg; William T Longstreth; Russell P Tracy; Bruce M Psaty; Joseph Ac Delaney
Journal:  Atherosclerosis       Date:  2022-05-14       Impact factor: 6.847

Review 2.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

Review 3.  Mast cells as effectors in atherosclerosis.

Authors:  Ilze Bot; Guo-Ping Shi; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-07       Impact factor: 8.311

Review 4.  Interaction between allergic asthma and atherosclerosis.

Authors:  Cong-Lin Liu; Jin-Ying Zhang; Guo-Ping Shi
Journal:  Transl Res       Date:  2015-10-09       Impact factor: 7.012

5.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.

Authors:  Sanne Willems; Daniël van der Velden; Paul H A Quax; Gert Jan de Borst; Jean-Paul P M de Vries; Frans L Moll; Johan Kuiper; René E M Toes; Saskia C A de Jager; Dominique P V de Kleijn; Imo E Hoefer; Gerard Pasterkamp; Ilze Bot
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 7.  Immune mechanisms in atherosclerosis, especially in diabetes type 2.

Authors:  Johan Frostegård
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555

8.  Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects.

Authors:  María Moreno; Josep Puig; Marta Serrano; José María Moreno-Navarrete; Francisco Ortega; Wifredo Ricart; Jose Manuel Fernandez-Real
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 9.  Atherosclerosis: a chronic inflammatory disease mediated by mast cells.

Authors:  Pio Conti; Yazdami Shaik-Dasthagirisaeb
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

Review 10.  Inflammation in Vein Graft Disease.

Authors:  Margreet R de Vries; Paul H A Quax
Journal:  Front Cardiovasc Med       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.